{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Iprindole  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Iprindole. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Iprindole  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "iprindole",
    "trial_2_text": "Iprindole  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Iprindole Supplement: 60 participants will take Iprindole 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Iprindole. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Iprindole  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.2555939555168152,
      "78": 0.1990167796611786,
      "177": 0.17996858060359955,
      "37": 0.1671701967716217,
      "123": 0.1619822084903717,
      "20": 0.15170738101005554,
      "21": 0.14981377124786377,
      "17": 0.1480282098054886,
      "68": 0.13911837339401245,
      "14": 0.13865156471729279,
      "46": 0.13636396825313568,
      "173": 0.13441947102546692,
      "77": 0.13200679421424866,
      "67": 0.1251583695411682,
      "49": 0.12352100759744644,
      "9": 0.11946017295122147,
      "2": 0.11815879493951797,
      "189": 0.115724116563797,
      "79": 0.11241882294416428,
      "114": 0.10629203170537949,
      "228": 0.10409899801015854,
      "350": 0.10404202342033386,
      "188": 0.1028406098484993,
      "200": 0.10076402127742767,
      "5": 0.0871051698923111,
      "193": 0.08539292216300964,
      "85": 0.08401115983724594,
      "101": 0.08283479511737823,
      "64": 0.08109256625175476,
      "243": 0.07861612737178802,
      "126": 0.07536458969116211,
      "29": 0.07407784461975098,
      "104": 0.07352320104837418,
      "86": 0.07160069048404694,
      "72": 0.07094075530767441,
      "27": 0.07024332880973816,
      "76": 0.06832663714885712,
      "239": 0.06811761111021042,
      "18": 0.06788454949855804,
      "180": 0.06784584373235703,
      "82": 0.06783977150917053,
      "28": 0.0671326294541359,
      "61": 0.06501636654138565,
      "131": 0.06402496993541718,
      "116": 0.061791613698005676,
      "144": 0.061133451759815216,
      "194": 0.06104110926389694,
      "179": 0.060641635209321976,
      "69": 0.059893108904361725,
      "102": 0.05927547812461853,
      "139": 0.057299524545669556,
      "30": 0.05653371289372444,
      "204": 0.05530520901083946,
      "1": 0.05523816868662834,
      "276": 0.05485299602150917,
      "186": 0.05390550196170807,
      "261": 0.053104035556316376,
      "396": 0.0531018003821373,
      "151": 0.05153968930244446,
      "191": 0.05094613507390022,
      "147": 0.05012885481119156,
      "122": 0.04975575953722,
      "234": 0.048621032387018204,
      "253": 0.04816747456789017,
      "92": 0.04669104889035225,
      "38": 0.04646771773695946,
      "35": 0.0451812781393528,
      "282": 0.04509216919541359,
      "269": 0.044881630688905716,
      "4": 0.04484865814447403,
      "130": 0.04437640681862831,
      "355": 0.04298189654946327,
      "75": 0.04294126108288765,
      "288": 0.042817093431949615,
      "221": 0.04256542772054672,
      "508": 0.042243488132953644,
      "466": 0.041651152074337006,
      "441": 0.040437471121549606,
      "153": 0.040315017104148865,
      "454": 0.04003984481096268,
      "97": 0.03986874595284462,
      "212": 0.03986724838614464,
      "382": 0.03980531170964241,
      "164": 0.03956704959273338,
      "96": 0.039324332028627396,
      "132": 0.038597527891397476,
      "262": 0.03854867443442345,
      "341": 0.03797713294625282,
      "249": 0.03777340427041054,
      "339": 0.037495434284210205,
      "199": 0.03682984039187431,
      "33": 0.03676091134548187,
      "286": 0.03566836565732956,
      "211": 0.03541666641831398,
      "163": 0.035374224185943604,
      "422": 0.035273969173431396,
      "400": 0.03504994139075279,
      "98": 0.03468038886785507,
      "100": 0.034240320324897766,
      "11": 0.034212626516819
    },
    "trial_2_ae": {
      "87": 0.2555939555168152,
      "78": 0.1990167796611786,
      "177": 0.17996858060359955,
      "37": 0.1671701967716217,
      "123": 0.1619822084903717,
      "20": 0.15170738101005554,
      "21": 0.14981377124786377,
      "17": 0.1480282098054886,
      "68": 0.13911837339401245,
      "14": 0.13865156471729279,
      "46": 0.13636396825313568,
      "173": 0.13441947102546692,
      "77": 0.13200679421424866,
      "67": 0.1251583695411682,
      "49": 0.12352100759744644,
      "9": 0.11946017295122147,
      "2": 0.11815879493951797,
      "189": 0.115724116563797,
      "79": 0.11241882294416428,
      "114": 0.10629203170537949,
      "228": 0.10409899801015854,
      "350": 0.10404202342033386,
      "188": 0.1028406098484993,
      "200": 0.10076402127742767,
      "5": 0.0871051698923111,
      "193": 0.08539292216300964,
      "85": 0.08401115983724594,
      "101": 0.08283479511737823,
      "64": 0.08109256625175476,
      "243": 0.07861612737178802,
      "126": 0.07536458969116211,
      "29": 0.07407784461975098,
      "104": 0.07352320104837418,
      "86": 0.07160069048404694,
      "72": 0.07094075530767441,
      "27": 0.07024332880973816,
      "76": 0.06832663714885712,
      "239": 0.06811761111021042,
      "18": 0.06788454949855804,
      "180": 0.06784584373235703,
      "82": 0.06783977150917053,
      "28": 0.0671326294541359,
      "61": 0.06501636654138565,
      "131": 0.06402496993541718,
      "116": 0.061791613698005676,
      "144": 0.061133451759815216,
      "194": 0.06104110926389694,
      "179": 0.060641635209321976,
      "69": 0.059893108904361725,
      "102": 0.05927547812461853,
      "139": 0.057299524545669556,
      "30": 0.05653371289372444,
      "204": 0.05530520901083946,
      "1": 0.05523816868662834,
      "276": 0.05485299602150917,
      "186": 0.05390550196170807,
      "261": 0.053104035556316376,
      "396": 0.0531018003821373,
      "151": 0.05153968930244446,
      "191": 0.05094613507390022,
      "147": 0.05012885481119156,
      "122": 0.04975575953722,
      "234": 0.048621032387018204,
      "253": 0.04816747456789017,
      "92": 0.04669104889035225,
      "38": 0.04646771773695946,
      "35": 0.0451812781393528,
      "282": 0.04509216919541359,
      "269": 0.044881630688905716,
      "4": 0.04484865814447403,
      "130": 0.04437640681862831,
      "355": 0.04298189654946327,
      "75": 0.04294126108288765,
      "288": 0.042817093431949615,
      "221": 0.04256542772054672,
      "508": 0.042243488132953644,
      "466": 0.041651152074337006,
      "441": 0.040437471121549606,
      "153": 0.040315017104148865,
      "454": 0.04003984481096268,
      "97": 0.03986874595284462,
      "212": 0.03986724838614464,
      "382": 0.03980531170964241,
      "164": 0.03956704959273338,
      "96": 0.039324332028627396,
      "132": 0.038597527891397476,
      "262": 0.03854867443442345,
      "341": 0.03797713294625282,
      "249": 0.03777340427041054,
      "339": 0.037495434284210205,
      "199": 0.03682984039187431,
      "33": 0.03676091134548187,
      "286": 0.03566836565732956,
      "211": 0.03541666641831398,
      "163": 0.035374224185943604,
      "422": 0.035273969173431396,
      "400": 0.03504994139075279,
      "98": 0.03468038886785507,
      "100": 0.034240320324897766,
      "11": 0.034212626516819
    }
  },
  "safety": {
    "trial_1_safety": 0.3202959895133972,
    "trial_2_safety": 0.3202959895133972
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.47969692945480347
  }
}